Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma

被引:4
作者
Fabregas, Jesus C. [1 ]
Carter, Benjamin T. [2 ,3 ]
Lutzky, Jose [4 ]
Robinson, William Russell, III [5 ]
Brant, Jeannine M. [2 ]
机构
[1] Univ Florida, Univ Florida Hlth Canc Ctr, 1600 SW Archer Rd,D2-3, Gainesville, FL 32610 USA
[2] Billings Clin, 2800 Tenth Ave North, Billings, MT 59107 USA
[3] Collaborat Sci & Innovat, 2800 Tenth Ave North, Billings, MT 59101 USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, 1475 NW Ave,Floor 2, Miami, FL 33136 USA
[5] Univ Mississippi, Dept Obstet & Gynecol, Med Ctr, J2500 N State St, Jackson, MS 39216 USA
关键词
Melanoma; Disparities; Staging diagnosis; Insurance; Ethics; CUTANEOUS MALIGNANT-MELANOMA; DISPARITIES; CANCER; STAGE; EPIDEMIOLOGY; SURVIVAL;
D O I
10.1007/s40615-021-01166-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Black patients are diagnosed with melanoma at a later stage, as compared with their white counterparts. It is unknown if Medicaid expansion might ameliorate this disparity. Methods Using data from the 2016 National Cancer Database, we conducted a retrospective cohort study. The primary objective was to evaluate whether being diagnosed with melanoma at a Medicaid Expansion State (MES) and black race are associated with a late diagnosis of melanoma. Main exposure: Being diagnosed in a MES. Secondary exposure: Race. Main outcome: Odds of Stage IV vs Stages 0-III at diagnosis. Univariate, multivariate logistic regression, and propensity score analyses were conducted to evaluate the potential associations. Sub-group analysis was conducted according to age < 65 or >= 65 years. Results A total of 216,604 patients were included, 40-90 years of age, <(X)over bar> 64 years [SD 12.47]. In univariate analysis, patients diagnosed in MES were 15% less likely (95% CI, 0.81-0.88) to be diagnosed with Stage IV melanoma. Black race (vs white) had 3.04 increased odds (95% CI, 2.56-3.60) of late diagnosis. In multivariate analysis, adjusting for socio-economic confounders, patients < 65 years of age were 13% less likely (95% CI, 0.82-0.92) to be diagnosed with Stage IV melanoma. By propensity score analysis, the strength of the associations remained. Black race (vs white) was associated with higher odds (95% CI, 1.91-3.08) of being diagnosed with Stage IV disease. For black patients < 65 years, being diagnosed in a state without Medicaid expansion had 2.55 higher odds (95% CI, 1.93-3.38) of being diagnosed with Stage IV melanoma, which decreased to 2.11 odds (95% CI, 1.34-3.33) in MES. The interaction between race and MES was statistically significant (P = 0.008). Conclusions This study suggests that patients are less likely to be diagnosed with Stage IV melanoma in MES. This beneficial effect is more pronounced among Black minorities.
引用
收藏
页码:2291 / 2299
页数:9
相关论文
共 41 条
  • [1] Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States
    Abudu, Boya
    Cook, Kaitlyn A.
    Gershenwald, Jeffrey E.
    Cohen, Philip R.
    Geller, Alan C.
    [J]. CANCER, 2020, 126 (04) : 775 - 781
  • [2] Disparities in the Presentation and Management of Cutaneous Melanoma That Required Admission
    Al-Qurayshi, Zaid
    Srivastav, Sudesh
    Wang, Alun
    Boh, Erin
    Hamner, John
    Hassan, Mohamed
    Kandil, Emad
    [J]. ONCOLOGY, 2018, 95 (02) : 69 - 80
  • [3] American College of Surgeons, NAT CANC DAT
  • [4] [Anonymous], Cancer stat facts: Cancer of any site
  • [5] Factors associated with time to surgery in melanoma: An analysis of the National Cancer Database
    Baranowski, Marissa L. H.
    Yeung, Howa
    Chen, Suephy C.
    Gillespie, Theresa W.
    Goodman, Michael
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : 908 - 916
  • [6] Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?
    Barbaric, Jelena
    Sekerija, Mario
    Agius, Dominic
    Coza, Daniela
    Dimitrova, Nadya
    Demetriou, Anna
    Diba, Chakameh Safaei
    Eser, Sultan
    Gavric, Zivana
    Primic-Zakelj, Maja
    Zivkovic, Snezana
    Zvolsky, Miroslav
    Bray, Freddie
    Coebergh, Jan Willem
    Znaor, Ariana
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 55 : 47 - 55
  • [7] Disparity on Unplanned Readmission in Melanoma Patients: A National Cancer Database Analysis
    Boczar, Daniel
    Restrepo, David J.
    Sisti, Andrea
    Huayllani, Maria T.
    Spaulding, Aaron C.
    Gabriel, Emmanuel
    Bagaria, Sanjay
    Parker, Alexander S.
    Leppin, Aaron L.
    Forte, Antonio J.
    [J]. ANTICANCER RESEARCH, 2019, 39 (12) : 6877 - 6880
  • [8] Analysis of Melanoma in African American Patients in the United States
    Boczar, Daniel
    Restrepo, David J.
    Sisti, Andrea
    Huayllani, Maria T.
    Saleem, Humza Y.
    Lu, Xiaona
    Cinotto, Gabriela
    Manrique, Oscar J.
    Spaulding, Aaron C.
    Forte, Antonio J.
    [J]. ANTICANCER RESEARCH, 2019, 39 (11) : 6333 - 6337
  • [9] Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
    Burton, A
    Altman, DG
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (01) : 4 - 8
  • [10] Cancer statistics for adults aged 85 years and older, 2019
    DeSantis, Carol E.
    Miller, Kimberly D.
    Dale, William
    Mohile, Supriya G.
    Cohen, Harvey J.
    Leach, Corinne R.
    Sauer, Ann Goding
    Lemal, Ahmedin
    Siegel, Rebecca L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (06) : 452 - 467